Firstly, clinical information downloaded from TCGA and CGGA databases is limited and incomplete, and secondly, the identified mechanism of ARGs affecting glioma development requires further in vivo and in vitro experimental studies. This evidence concerns the gene SERPINA2 and central nervous system cancer.